A recent publication from the Shanghai Men’s Health study reported that CYP2A6 genetic variants confirmed to be associated with a reduced enzymatic activity were associated with a decreased risk of lung cancer (odds ratio [OR] = 0.64; p = 0.03) [11]. The gene discussed is CYP2A6; the disease is lung carcinoma.